Chinese biotech 3SBIO launches up to $712 mln HK IPO - Reuters
Biotech company 3SBIO, which delisted from the Nasdaq two years ago, on Wednesday launched an up to $712 million IPO in Hong Kong to fund acquisitions and recruit staff to help it grab a bigger piece of the booming Chinese drug market.
27 May 2015•2 mins read
